Molecular Partners AG (MLLCF) Financials

MLLCF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 93.1 million 21.1 million
March 31, 2026 109.7 million 24.0 million
Dec. 31, 2025 128.8 million 27.5 million
Sept. 30, 2025 140.8 million 20.9 million

MLLCF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -13.1 million ?
March 31, 2026 -17.7 million 1.2 million
Dec. 31, 2025 -13.8 million 1.2 million
Sept. 30, 2025 -12.5 million 1.4 million

MLLCF Net Income

No data available :(

MLLCF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 83.5 million - 2.3 million
March 31, 2026 98.6 million - 4.2 million
Dec. 31, 2025 117.3 million - 4.6 million
Sept. 30, 2025 131.2 million - 1.9 million

MLLCF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 48.0 million
March 31, 2026 46.8 million
Dec. 31, 2025 47.2 million
Sept. 30, 2025 47.0 million

MLLCF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 24588 11.7 million 4.9 million -
March 31, 2026 - 11.8 million 4.4 million -
Dec. 31, 2025 175276 11.7 million 3.7 million -
Sept. 30, 2025 38924 10.5 million 4.5 million -

MLLCF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 595058
March 31, 2026 - 627009
Dec. 31, 2025 - 646884
Sept. 30, 2025 - 10.5 million

MLLCF

Price: $4.01

52 week price:
2.25
4.96

Earnings Per Share: -1.68 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 150.4 million

Links: